Cogna Technology Solutions LLC
Quick facts
Phase 3 pipeline
- BBIBP-CorV vaccine · Immunology / Infectious Disease
BBIBP-CorV is an inactivated whole-virus COVID-19 vaccine that stimulates immune responses against SARS-CoV-2.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Cogna Technology Solutions LLC portfolio CI brief
- Cogna Technology Solutions LLC pipeline updates RSS
Frequently asked questions about Cogna Technology Solutions LLC
What is Cogna Technology Solutions LLC's pipeline?
Cogna Technology Solutions LLC has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include BBIBP-CorV vaccine.
Related
- Sector hub: All tracked pharma companies